SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-15-026653
Filing Date
2015-04-30
Accepted
2015-04-30 17:12:06
Documents
9
Period of Report
2015-06-18
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A v408897_def14a.htm DEF 14A 1125020
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_novavax-tag.jpg GRAPHIC 108920
4 GRAPHIC sig_stanley-erck.jpg GRAPHIC 20134
5 GRAPHIC logo_novavax.jpg GRAPHIC 39085
6 GRAPHIC sig_john-herrmann3.jpg GRAPHIC 14491
7 GRAPHIC spacer.gif GRAPHIC 43
8 GRAPHIC v408897_proxy-1.jpg GRAPHIC 686771
9 GRAPHIC v408897_proxy-2.jpg GRAPHIC 414159
  Complete submission text file 0001144204-15-026653.txt   2895815
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26770 | Film No.: 15820217
SIC: 2836 Biological Products, (No Diagnostic Substances)